Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.32
-1.85 %
$ 907 M
Market Cap
-15.74
P/E
Price Target
Average
67.60%
Revenue Forecast
Estimate
52.36%
EBIT
Estimate
--108.69%
Net Income
Estimate
64.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evolus, Inc.
Wall Street analysts predict an average 1-year price target for EOLS of $24 , with forecasts ranging from
a
low of
$20 to a high of $27 .
EOLS Lowest Price Target
Wall Street Target
20 USD
39.66%
EOLS Average Price Target
Wall Street Target
24 USD
67.60%
EOLS Highest Price Target
Wall Street Target
27 USD
88.55%
REVENUE FORECAST
Revenue Forecast Chart EOLS
EBIT FORECAST
EBIT Forecast Chart EOLS
NET INCOME FORECAST
Net Income Chart EOLS